Logo image of MHUA

MEIHUA INTERNATIONAL MEDICAL (MHUA) Stock Fundamental Analysis

NASDAQ:MHUA - Nasdaq - KYG5966G1082 - Common Stock - Currency: USD

0.362  -0.01 (-1.92%)

Fundamental Rating

5

Taking everything into account, MHUA scores 5 out of 10 in our fundamental rating. MHUA was compared to 187 industry peers in the Health Care Equipment & Supplies industry. While MHUA has a great health rating, its profitability is only average at the moment. MHUA has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

MHUA had positive earnings in the past year.
In the past year MHUA had a positive cash flow from operations.
MHUA had positive earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: MHUA reported negative operating cash flow in multiple years.
MHUA Yearly Net Income VS EBIT VS OCF VS FCFMHUA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

Looking at the Return On Assets, with a value of 8.35%, MHUA belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
MHUA has a better Return On Equity (9.79%) than 84.49% of its industry peers.
MHUA has a Return On Invested Capital of 9.47%. This is amongst the best in the industry. MHUA outperforms 90.37% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MHUA is in line with the industry average of 8.14%.
The last Return On Invested Capital (9.47%) for MHUA is above the 3 year average (6.66%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.35%
ROE 9.79%
ROIC 9.47%
ROA(3y)5.46%
ROA(5y)9.91%
ROE(3y)6.42%
ROE(5y)12.22%
ROIC(3y)6.66%
ROIC(5y)11.82%
MHUA Yearly ROA, ROE, ROICMHUA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 10.94%, MHUA belongs to the top of the industry, outperforming 84.49% of the companies in the same industry.
MHUA's Profit Margin has declined in the last couple of years.
The Operating Margin of MHUA (14.20%) is better than 82.89% of its industry peers.
In the last couple of years the Operating Margin of MHUA has declined.
The Gross Margin of MHUA (34.08%) is worse than 72.19% of its industry peers.
In the last couple of years the Gross Margin of MHUA has declined.
Industry RankSector Rank
OM 14.2%
PM (TTM) 10.94%
GM 34.08%
OM growth 3Y-16.41%
OM growth 5Y-9.53%
PM growth 3Y-17.73%
PM growth 5Y-10.37%
GM growth 3Y-3.53%
GM growth 5Y-3.21%
MHUA Yearly Profit, Operating, Gross MarginsMHUA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MHUA is still creating some value.
MHUA has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, MHUA has more shares outstanding
MHUA has about the same debt/assets ratio as last year.
MHUA Yearly Shares OutstandingMHUA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MHUA Yearly Total Debt VS Total AssetsMHUA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 3.04 indicates that MHUA is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.04, MHUA is doing good in the industry, outperforming 68.45% of the companies in the same industry.
The Debt to FCF ratio of MHUA is 0.55, which is an excellent value as it means it would take MHUA, only 0.55 years of fcf income to pay off all of its debts.
MHUA has a Debt to FCF ratio of 0.55. This is amongst the best in the industry. MHUA outperforms 93.58% of its industry peers.
MHUA has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.05, MHUA is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.55
Altman-Z 3.04
ROIC/WACC1.7
WACC5.57%
MHUA Yearly LT Debt VS Equity VS FCFMHUA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 5.26 indicates that MHUA has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 5.26, MHUA is in the better half of the industry, outperforming 76.47% of the companies in the same industry.
MHUA has a Quick Ratio of 5.21. This indicates that MHUA is financially healthy and has no problem in meeting its short term obligations.
MHUA has a better Quick ratio (5.21) than 80.75% of its industry peers.
Industry RankSector Rank
Current Ratio 5.26
Quick Ratio 5.21
MHUA Yearly Current Assets VS Current LiabilitesMHUA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for MHUA have decreased strongly by -29.57% in the last year.
Measured over the past years, MHUA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -13.75% on average per year.
The Revenue has decreased by -2.09% in the past year.
The Revenue has been growing slightly by 4.01% on average over the past years.
EPS 1Y (TTM)-29.57%
EPS 3Y-27.74%
EPS 5Y-13.75%
EPS Q2Q%-18.41%
Revenue 1Y (TTM)-2.09%
Revenue growth 3Y-2.33%
Revenue growth 5Y4.01%
Sales Q2Q%-0.19%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MHUA Yearly Revenue VS EstimatesMHUA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 0.66 indicates a rather cheap valuation of MHUA.
MHUA's Price/Earnings ratio is rather cheap when compared to the industry. MHUA is cheaper than 99.47% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.82. MHUA is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 0.66
Fwd PE N/A
MHUA Price Earnings VS Forward Price EarningsMHUA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of MHUA indicates a rather cheap valuation: MHUA is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 0.8
EV/EBITDA -0.2
MHUA Per share dataMHUA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The decent profitability rating of MHUA may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MHUA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MEIHUA INTERNATIONAL MEDICAL

NASDAQ:MHUA (8/4/2025, 9:56:39 AM)

0.362

-0.01 (-1.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-29 2022-11-29/bmo
Earnings (Next)N/A N/A
Inst Owners1.06%
Inst Owner Change0%
Ins Owners49.95%
Ins Owner ChangeN/A
Market Cap11.55M
AnalystsN/A
Price TargetN/A
Short Float %0.12%
Short Ratio0.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.66
Fwd PE N/A
P/S 0.08
P/FCF 0.8
P/OCF 0.79
P/B 0.07
P/tB 0.07
EV/EBITDA -0.2
EPS(TTM)0.55
EY151.93%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.45
FCFY125.59%
OCF(TTM)0.46
OCFY126.75%
SpS4.46
BVpS4.98
TBVpS4.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.35%
ROE 9.79%
ROCE 12.71%
ROIC 9.47%
ROICexc 10.48%
ROICexgc 10.51%
OM 14.2%
PM (TTM) 10.94%
GM 34.08%
FCFM 10.2%
ROA(3y)5.46%
ROA(5y)9.91%
ROE(3y)6.42%
ROE(5y)12.22%
ROIC(3y)6.66%
ROIC(5y)11.82%
ROICexc(3y)7.64%
ROICexc(5y)13.07%
ROICexgc(3y)7.74%
ROICexgc(5y)13.18%
ROCE(3y)8.91%
ROCE(5y)15.78%
ROICexcg growth 3Y-27.75%
ROICexcg growth 5Y-25.86%
ROICexc growth 3Y-27.69%
ROICexc growth 5Y-25.71%
OM growth 3Y-16.41%
OM growth 5Y-9.53%
PM growth 3Y-17.73%
PM growth 5Y-10.37%
GM growth 3Y-3.53%
GM growth 5Y-3.21%
F-Score4
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.55
Debt/EBITDA 0.38
Cap/Depr 23.4%
Cap/Sales 0.09%
Interest Coverage 81.6
Cash Conversion 70.45%
Profit Quality 93.21%
Current Ratio 5.26
Quick Ratio 5.21
Altman-Z 3.04
F-Score4
WACC5.57%
ROIC/WACC1.7
Cap/Depr(3y)500.19%
Cap/Depr(5y)470.87%
Cap/Sales(3y)2.53%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.57%
EPS 3Y-27.74%
EPS 5Y-13.75%
EPS Q2Q%-18.41%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.09%
Revenue growth 3Y-2.33%
Revenue growth 5Y4.01%
Sales Q2Q%-0.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.01%
EBIT growth 3Y-18.36%
EBIT growth 5Y-5.9%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y701.6%
FCF growth 3YN/A
FCF growth 5Y109.43%
OCF growth 1Y543.15%
OCF growth 3YN/A
OCF growth 5Y9.47%